Business ❯ Finance ❯ Investor Relations

Securities Fraud

Litigation Process False Claims Legal Recourse

Unicycive Investors Urged to Seek Lead Role in Securities Suit Ahead of Oct. 14 Deadline

Plaintiff notices tie investor losses to June 2025 FDA findings that allegedly revealed overstatements about manufacturing compliance.